Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2a study of voxelotor in pediatric participants with sickle cell disease
2016-004209-15Phase 2Unknown
- Sponsor
- Global Blood Therapeutics, Inc.
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of voxelotor in sickle cell disease (SCD), sponsored by Global Blood Therapeutics, Inc. Status: unknown.
02
Drugs
voxelotor
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on 2016-004209-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004209-15.